Pluristem Therapeutics, Inc. PSTIW Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Pluristem Therapeutics, Inc. PSTIW Company Overview 

Stock Message Board http://investorshangout.com/search?q=PSTIW&am...mp;yt1=Go!

Pluristem Therapeutics, Inc. PSTIW Current Price and Quotes
Last Price 0.28
Previous Close 0.28 Open N/A
Daily Range N/A - N/A 52wk Range 0.45 - 0.10
Volume 0 Dividend N/A
Average Vol (3m) 18,507 Yield N/A
Pluristem Therapeutics, Inc. PSTIW
Company Information

Matam Advanced Technology Park
Building No. 20
Haifa 31905
Israel

Phone: 011-972-4-850-1080

Pluristem Therapeutics, Inc. PSTIW
Not Available

Pluristem Therapeutics, Inc. PSTIW
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Reporting - Investment Company
Latest Report Mar 31, 2013 10-Q
CIK 0001158780
Fiscal Year End 6/30
OTC Marketplace Grey Market
Profile Data

SIC - Industry Classification
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Menachem (Mendi) Ze'evi CEO
Company Directors

Not Available
Company Notes

Formerly=Pluristem Life Systems, Inc. until 11-07
Note=6-30-04 company is in the development stage
Formerly=A.I. Software, Inc. until 6-03
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Pluristem Therapeutics, Inc. PSTIW
PSTIW Security Details Other Company Securities

Share Structure

Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value  Not Available
Shareholders

Shareholders of Record Not Available
Short Selling Data

Short Interest 0 (-100%)
Feb 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Pluristem Therapeutics, Inc. PSTIW Recent News

Aug 14, 2013 Tendon Injuries Treated With Pluristem's PLX Cells Demonstrate Favorable Properties
Aug 6, 2013 Pluristem Awarded a $3.3 Million Grant by Israeli Government
Jul 18, 2013 U.S. National Institutes of Health Recommend to Expand Its Scope of Research in the Development of Pluristem's PLX-RAD Cells for the Treatment of Acute Radiation Syndrome
Jul 11, 2013 Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial
Jul 8, 2013 Pluristem's South Korean Partner Files IND With Korean FDA for PLX Cells
Jun 26, 2013 Pluristem signs Korean licensing agreement
Jun 26, 2013 Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercialization of PLX Cells for the Treatment of CLI and IC in South Korea
Jun 20, 2013 Pluristem's Preclinical Results for Its PLX-RAD Cells Published in the Journal PLOS ONE
Jun 19, 2013 Pluristem Provides Update on Clinical Status of IC Trials


Pluristem Therapeutics, Inc. PSTIW Financials
Period Ending Jun 30, 2012
Total Revenue 716
Cost of Revenue -
Gross Profit 716
Operating Expenses

Research and Development 9,179
Sales, General and Admin. 6,568
Non-Recurring Items -
Other -
Operating Income (15,031)
Income From Continuing Operations

Add'l Income/Expense Items -
Earnings Before Interest and Tax (14,794)
Interest Expense -
Earnings Before Tax (14,794)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (14,794)
Non Recurring Events

Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (14,794)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (14,794)

PSTIW Pluristem Therapeutics, Inc. Research DD Guide

PSTIW Pluristem Therapeutics, Inc. Stock Message Board http://investorshangout.com/search?q=PSTIW&am...mp;yt0=Go!
PSTIW Pluristem Therapeutics, Inc. Stock Quote http://www.otcmarkets.com/stock/PSTIW/quote
PSTIW Pluristem Therapeutics, Inc. Stock Chart http://www.otcmarkets.com/stock/PSTIW/chart
PSTIW Pluristem Therapeutics, Inc. Company Info http://www.otcmarkets.com/stock/PSTIW/company-info
PSTIW Pluristem Therapeutics, Inc. Recent News http://www.otcmarkets.com/stock/PSTIW/news
PSTIW Pluristem Therapeutics, Inc. Financials http://www.otcmarkets.com/stock/PSTIW/financials
PSTIW Pluristem Therapeutics, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/PSTIW/filings
PSTIW Pluristem Therapeutics, Inc. Short Sales http://www.otcmarkets.com/stock/PSTIW/short-sales
PSTIW Pluristem Therapeutics, Inc. Insider Disclosure http://www.otcmarkets.com/stock/PSTIW/insider-transactions
PSTIW Pluristem Therapeutics, Inc. Research Reports http://www.otcmarkets.com/stock/PSTIW/research
PSTIW Pluristem Therapeutics, Inc. Summary http://finance.yahoo.com/q?s=PSTIW
PSTIW Pluristem Therapeutics, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=PSTIW+Historical+Prices
PSTIW Pluristem Therapeutics, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=PSTIW
PSTIW Pluristem Therapeutics, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=PSTIW+Basic+Chart
PSTIW Pluristem Therapeutics, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PSTIW+Basic+Tech.+Analysis
PSTIW Pluristem Therapeutics, Inc. Headlines http://finance.yahoo.com/q/h?s=PSTIW+Headlines
PSTIW Pluristem Therapeutics, Inc. Press Releases http://finance.yahoo.com/q/p?s=PSTIW+Press+Releases
PSTIW Pluristem Therapeutics, Inc. Company Profile http://finance.yahoo.com/q/pr?s=PSTIW+Profile
PSTIW Pluristem Therapeutics, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=PSTIW+Key+Statistics
PSTIW Pluristem Therapeutics, Inc. Industry http://finance.yahoo.com/q/in?s=PSTIW+Industry
PSTIW Pluristem Therapeutics, Inc. Major Holders http://finance.yahoo.com/q/mh?s=PSTIW+Major+Holders
PSTIW Pluristem Therapeutics, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=PSTIW+Insider+Transactions
PSTIW Pluristem Therapeutics, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=PSTIW+Insider+Roster
PSTIW Pluristem Therapeutics, Inc. Income Statement http://finance.yahoo.com/q/is?s=PSTIW
PSTIW Pluristem Therapeutics, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=PSTIW
PSTIW Pluristem Therapeutics, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=PSTIW+Cash+Flow&annual
PSTIW Pluristem Therapeutics, Inc. Nasdaq http://www.nasdaq.com/symbol/PSTIW
PSTIW Pluristem Therapeutics, Inc. Market Watch http://www.marketwatch.com/investing/stock/PSTIW
PSTIW Pluristem Therapeutics, Inc. Bloomberg http://www.bloomberg.com/quote/PSTIW:US
PSTIW Pluristem Therapeutics, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=PSTIW
PSTIW Pluristem Therapeutics, Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=PSTIW
PSTIW Pluristem Therapeutics, Inc. Barchart http://www.barchart.com/quotes/stocks/PSTIW
PSTIW Pluristem Therapeutics, Inc. OTC Short Report http://otcshortreport.com/index.php?index=PSTIW
PSTIW Pluristem Therapeutics, Inc. Investopedia http://www.investopedia.com/markets/stocks/PSTIW/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

Updated Category News Views 2

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 7

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Standex's New Financial Lead: Stoddard Takes Helm

Updated Category News Views 2

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Continue Reading
Baidu Faces Class Action: Investors Push Against Fraud Allegations

Updated Category News Views 6

Baidu Under Fire for Alleged Misleading Statements Here's a fresh slice of drama straight outta the corporate trenches: Baidu, Inc. (NASDAQ: BIDU) finds itself tangled in a securities fraud lawsuit that’s causing a ruckus across investor circles. Schall, Brown & Schwartz LLP, those heavyweight gladiators in shareholder rights, are calling on grieved investors to step up...

Continue Reading
Encompass Health: Leader in Rehabilitation Again in 2026

Updated Category News Views 1

Pinnacle of Rehab: Encompass Health's Notable Streak You know, in a world where healthcare accolades fly around like confetti, Encompass Health Corp's persistence in being named America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek for the seventh straight year is something to chew on. The fact that a record 78 of its hospitals dotted across 32 states...

Continue Reading
FLUX 3 Max Launches with Unmatched Speed and Quality

Updated Category News Views 2

A Lightning Fast Leap in Video Generation It's all eyes on FLUX 3 Max today. You can almost hear the gasps of 'wow' in the generative media crowd. Why? Because this new weapon in the video gen arsenal, dreamed up by fal and Black Forest Labs, is slicing through the old speed limits like a blistering comet. Now, don't get me wrong. Seeds don't grow overnight, and neither...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 15

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
TilePix Expands into Walmart with Nail-Free Decor Launch

Updated Category News Views 6

TilePix Makes Big Moves with Walmart TilePix is launching their new line of nail-free wall décor at Walmart—this ain’t your grandma’s wall art. This company's bringing their magnetic, nail-free wizardry to retail stores nationwide for the first time, and they’ve chosen a real heavyweight partner—Walmart. What comes in the package? Well, they’re dealing in...

Continue Reading
Steel Dynamics' Q3 2026: Record Shipments Boost Profits

Updated Category News Views 1

Steel Dynamics Shatters Records in Q3 2026 If there was any doubt about Steel Dynamics' ability to ride the waves in the steel and aluminum market, the third quarter of 2026 put that to rest. With a record-breaking 3.8 million tons of steel shipped and net sales reaching a steep $6.5 billion, this isn't just business as usual—it's smashing their own ceiling. Operating...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 2

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading

Top 5 Most Recently Viewed Articles

How Infrastructure Expansion Is Creating New Property Hotspots in Dubai

Updated Category Real Estate Views 198

Dubai has long been recognized for its ambitious urban development, but in recent years, infrastructure expansion has become one of the biggest drivers of the city's real estate growth. Large-scale investments in transportation networks, roads, airports, public facilities, and mixed-use communities are transforming previously underdeveloped areas into highly desirable...

Continue Reading
SAP's Stock Growth: Analyzing Current Trends and Future Prospects

Updated Category News Views 358

SAP's Impressive Stock Performance SAP SE has seen a remarkable year-to-date stock increase of 36.7%, significantly outpacing the S&P 500's gain of 13.3%. This strong performance has led to growing investor optimism about SAP's long-term potential, especially as the company demonstrates resilience in a constantly changing market. Current Stock Analysis At present, SAP's...

Continue Reading
AmpliTech Group Secures $10 Million Funding Through Share Sale

Updated Category News Views 168

AmpliTech Group Announces Major Share Offering AmpliTech Group, Inc., a pioneer in signal processing components, has recently disclosed an exciting opportunity for investments. The company is set to engage in a registered direct offering, aiming to raise $10 million through the sale of its shares. This move highlights AmpliTech's strategic approach to funding its...

Continue Reading
Ark Invest's Latest Moves: Insights on Stock Trades

Updated Category News Views 149

Ark Invest's Recent Stock Trades and What They Mean The trading activities of Ark Invest, under the leadership of Cathie Wood, have recently sparked interest. The firm has been actively selling shares in prominent companies like Robinhood Markets Inc and Palantir Technologies Inc. This article takes a closer look at these transactions and their implications for the...

Continue Reading
Dollar Steady Ahead of Crucial U.S. Labor Data Release

Updated Category News Views 98

The Dollar Holds Steady as Traders Await Key Labor Reports By Ankur Banerjee The dollar continues to stay near a two-week high against both the yen and the euro. As investors prepare for a series of important economic updates, particularly the U.S. payroll data set to be released on Friday, there is increasing speculation about possible interest rate changes from the...

Continue Reading